e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Current and emerging anti-inflammatory therapies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Glucocorticoid potency correlates with transcriptional induction of a glucocorticoid regulated gene in human monocytes
A. Valotis, P. Högger (Würzburg, Germany)
Source:
Annual Congress 2005 - Current and emerging anti-inflammatory therapies
Session:
Current and emerging anti-inflammatory therapies
Session type:
Thematic Poster Session
Number:
2383
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Valotis, P. Högger (Würzburg, Germany). Glucocorticoid potency correlates with transcriptional induction of a glucocorticoid regulated gene in human monocytes. Eur Respir J 2005; 26: Suppl. 49, 2383
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Transactivation and transrepression in the repression of inflammatory gene expression by dexamethasone
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Transcriptional regulation of IL-4 gene expression
Source: Annual Congress 2004 - Transcription factors in airway disease
Year: 2004
Synergistic action of formoterol on budesonide-generated decrease of proteoglycan production by activated lung fibroblasts is mediated via β-adrenergic receptor and is dependent on glucocorticoid receptor
Source: Eur Respir J 2004; 24: Suppl. 48, 345s
Year: 2004
Glucocorticoids promote TGF-β signalling in lung fibroblasts by upregulating ligand and receptor expression, and uncoupling negative-feedback inhibition
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
NF-AT and GATA3 complex mediates anti-CD3/CD28-induced IL-13 expression: effect of glucocorticoid
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
Glucocorticoid-induced adrenal suppression and metabolic syndrome in glucocorticoid treated AECOPD patients related to different gene polymorphisms of the glucocorticoid receptor gene
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020
Importin-7 knockdown reduces corticosteroid induced glucocorticoid receptor nuclear localisation and suppression of IL-1beta induced CXCL8
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Hypoxia-induced methylation of the Thy-1 promoter is associated with transcriptional repression in human primary lung fibroblasts
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Muscarinic receptor stimulation differentially regulates extracellular matrix gene expression in lung fibroblasts
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011
Corticosteroid effects on cell signalling
Source: Eur Respir J 2006; 27: 413-426
Year: 2006
PP103 – Dysregulation of ZFP36L1 and ZFP36L2 in asthma alters epithelial integrity and genome-wide glucocorticoid responses
Source: ERS Lung Science Conference 2021
Year: 2021
Common IRF1 promoter polymorphisms induce changes in transcription factor binding subsequently affecting IRF1 gene expression
Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis
Year: 2008
Evidence for potential autocrine regulation of human airway smooth muscle cell functions by neurokinins: modulation of gene expression by glucocorticoids
Source: Eur Respir J 2003; 22: Suppl. 45, 11s
Year: 2003
Dysregulation of ZFP36L1 and ZFP36L2 in severe asthma alters epithelial integrity and dampens genome-wide glucocorticoid responses
Source: Virtual Congress 2021 – Early manifestations of chronic respiratory disease: zooming in at the epithelial barrier
Year: 2021
Airway neutrophils have reduced glucocorticoid receptor expression
Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD
Year: 2008
Effects of triptolide on T lymphocyte activation and transcription of interleukin-5 gene and its mechanisms
Source: Eur Respir J 2003; 22: Suppl. 45, 483s
Year: 2003
Involvement of C/EBPbeta and delta in lung glucocorticoid signaling
Source: Eur Respir J 2002; 20: Suppl. 38, 372s
Year: 2002
Gene transfer of a β-adrenergic receptor kinase inhibitor up-regulated levels of β-adrenergic receptor and cAMP in asthmatic murine lung
Source: Eur Respir J 2005; 26: Suppl. 49, 580s
Year: 2005
Dexamethasone inhibits LPS-induced expression of human β-defensin-2 via down-regulation of TLR4
Source: Eur Respir J 2003; 22: Suppl. 45, 562s
Year: 2003
Generation and activation of myeloid derived suppressor cells using prostaglandin E2 and EP receptor agonists in vitro
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept